COX inhibition in liver disease.
Abstract
We describe here from measurement of total transcription by transcriptomic methods for identification of viable therapeutic target discovery of a suite of cytochrome oxidase enzymes of the COX family for treatment of chronic liver disease, among the ten leading causes of death (mortality) among humans in the developed world.
Fields of Study & Subjects
Inflammatory mediators and NSAID effects
Drug-Induced Hepatotoxicity and Protection
Liver physiology and pathology
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 19 January 2026
- Document type
- Preprint